PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$308.94
+3.57 (+1.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+1.43%
1Y
+612.99%
YTD
+7.87%
Open$303.93
Previous Close$305.37
Day High$316.59
Day Low$302.50
52W High$366.52
52W Low$37.19
Volume—
Avg Volume528.8K
Market Cap7.87B
P/E Ratio—
EPS$-13.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$296.27
Above
SMA 200
$133.67
Above
RSI (14)
61.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-93.7% upside
Current
$308.94
$308.94
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |